The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas

Annals of Surgery

Volumn 255, Issue 3, 2012, Pages 517-522

  Hirono, Seiko ^a   Tani, Masaji ^a   Kawai, Manabu ^a   Okada, Ken Ichi ^a   Miyazawa, Motoki ^a   Shimizu, Atsushi ^a   Kitahata, Yuji ^a   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; DIAGNOSTIC VALUE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; JAUNDICE; MAJOR CLINICAL STUDY; MALE; PANCREAS DUCT; PANCREAS JUICE; PANCREAS TUMOR; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TUMOR LOCALIZATION; TUMOR VOLUME;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC JUICE; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 84857656806     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3182444231     Document Type: Article

References (21)

1. Kloppel G, Solcia E, Longnecker DS, et al. Histologic Typing of Tumors of the Exocrine Pancreas. 2nd ed. Geneva, Switzerland: Springer-Verlag; 1996.
2. Kawai M, Uchiyama K, Tani M, et al. Clinicopathological features of malignant intraductal papillary mucinous tumors of the pancreas. Arch Surg. 2004;139:188-192.
3. Hirono S, Tani M, Kawai M, et al. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors. Arch Surg. 2009;144:345-349.
4. Jang JY, Hwang DW, Kim MA, et al. Analysis of prognostic factors and a proposed new classification for invasive papillary mucinous neoplasms. Ann Surg Oncol. 2011;18:644-650.
5. Murakami Y, Uemura K, Hayashidani Y, et al. Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas. J Gastroitest Surg. 2007;11:338-344.
6. Hwang DW, Jang JY, Lee SE, et al. Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution. Langenbecks Arch Surg. 2012;397:93-102.
7. Wasif N, Bentrem DJ, Farrell JJ, et al. Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma. Cancer. 2010;116:3369-3377.
8. Poultsides GA, Reddy S, Cameron JL, et al. Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm associated invasive adenocarcinoma of the pancreas. Ann Surg. 2010;251:470-476.
9. Yopp AC, Katabi N, Janakos M, et al. Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas. A matched control study with conventional pancreatic ductal adenocarcinoma. Ann Surg. 2011;253:968-974.
10. Schmidt CM, White PB, Waters JA, et al. Intraductal papillary mucinous neoplasms. Predictors of malignant and invasive pathology. Ann Surg. 2007;246:644-654.
11. Jang JY, Kim SW, Lee SE, et al. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when canwe operate or observe? Ann Surg Oncol. 2007;15:199-205.
12. Akita H, Takeda Y, Hoshino H, et al. Mural nodule in branch duct-type intraductal papillary mucinous neoplasms of the pancreas is a marker of malignant transformation and indication for surgery. Am J Surg. 2011;202:214-219.
13. Shimizu Y, Kanemitsu Y, Sano T, et al. A nomogram for predicting the probability of carcinoma in patients with intraductal papillary mucinous neoplasm. World J Surg. 2010;34:2932-2938.
14. Salvia R, Crippa S, Falconi M, et al. Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Gut. 2007;56:1086-1090.
15. Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383-393.
16. Weinberg BM, Spiegel BMR, Tomlinson JS, et al. Asymptomatic pancreatic cyst neoplasms: maximizing survival and quality of life using Markov-based clinical nomograms. Gastroenterology. 2010;138:531-540.
17. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms andmucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17-32.
18. Maker AV, Lee LS, Raut CP, et al. Cytology from pancreatic cysts has marginal utility in surgical decision-making. Ann Surg Oncol. 2008;15:3187-3192.
19. Paris SA, Attasaranya S, Leblanc JK, et al. Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: correlation with surgical histopathology. Clin Gastroenterol Hepatol. 2007;5:489-495.
20. Maire F, Voitot H, Aubert A, et al. Intraductal papillary mucinous neoplasms of the pancreas: performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. Am J Gasetroenterol. 2008;103:2871-2877.
21. Jong K, Poley JW, Hooft JE, et al. Endoscopic ultrasound-guided fine-needle aspiration of pancreatic cyst lesions provides inadequate material for cytology and laboratory analysis: initial results from a prospective study. Endoscopy. 2011;43:585-590.